Tech Company Financing Transactions
Fortress Biotech Funding Round
Fortress Biotech secured a $3.3 million funding round on 4/21/2017. Backers included private investors.
Transaction Overview
Company Name
Announced On
4/21/2017
Transaction Type
Debt
Amount
$3,254,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2 Gansevoort Street 9th Floor
New York, NY 10014
USA
New York, NY 10014
USA
Phone
Website
Email Address
Not Recorded
Overview
Fortress Biotech is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lindsay Rosenwald
Chief Financial Officer
Lucy Lu
VP - Operations
George Avgerinos
Browse more venture capital transactions:
Prev: 4/21/2017: MediaHound venture capital transaction
Next: 4/21/2017: ReloQuest venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs